Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05896228
Title Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma (Iber-KDd)
Acronym Iber-KDd
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Carl Ola Landgren, MD, PhD
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33136 United States Details
*Shaded cells indicate that there was no data available from for the field